Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

ADDIT-CE

Financiado

Alzheimer's Disease Diagnostics Innovation and Translation to Clinical Practice...

Alzheimer's Disease Diagnostics Innovation and Translation to Clinical Practice in Central Europe More than 55 million people worldwide suffer from dementia. Alzheimer disease (AD) is the main cause of this fatal disorder, without any effective disease modifying therapy. Early diagnosis and lifestyle modifications can signific... ver más

31/12/2026

5M€

Presupuesto del proyecto: 5M€

Líder del proyecto

Masarykova univerzita No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 12 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-11-10

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-WIDERA-2022-ACCESS-04-01: Excellence Hubs

Innovación

Cerrada hace 2 años

0% 100%

12 Participantes

1.66M€ | Lider

FNUSA ICRC

580.93K€ | Participante

SLOVAK ACADEMY OF SCIENCES

238.59K€ | Participante

Proyectos interesantes

ADVANCE-AD Novel biomarkers for improving diagnostics, prognostics, and... 3M€ Cerrado

EIN2019-103424 APROXIMACION MULTIOMICA PARA EL DIAGNOSTICO PRECOZ DE LA ENF... 25K€ Cerrado

EPAD European Prevention of Alzheimer’s Dementia Consortium 60M€ Cerrado

STRATA-ALZ Optimizing stratification for trial design in Alzheimer’s di... 207K€ Cerrado

PID2021-123087OB-I00 SISTEMAS INTELIGENTES BASADOS EN BIOMARCADORES PARA SALUD 120K€ Cerrado

ADEEPSLEEP Focusing on deep sleep-wake brain regions in the context of... 273K€ Cerrado

Últimas noticias

27-11-2024: Videojuegos y creaci... Se abre la línea de ayuda pública: Ayudas para la promoción del sector del videojuego, del pódcast y otras formas de creación digital

27-11-2024: DGIPYME En las últimas 48 horas el Organismo DGIPYME ha otorgado 1 concesiones

27-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 2 concesiones

Duración del proyecto: 49 meses Fecha Inicio: 2022-11-10
Fecha Fin: 2026-12-31

Líder del proyecto

Masarykova univerzita

TRL 4-5

Presupuesto del proyecto 5M€

Descripción del proyecto More than 55 million people worldwide suffer from dementia. Alzheimer disease (AD) is the main cause of this fatal disorder, without any effective disease modifying therapy. Early diagnosis and lifestyle modifications can significantly reduce the costs of care and treatment. There is no conceptual plan implementing modern diagnostic methods in the clinical practice in Czechia and Slovakia. The interaction between universities and private sector developing molecular diagnostic tools is fragmented and lacking. Limited number of talented students are invested in applied AD-focused research. The aim of ADDIT-CE is to interlink two ecosystems in Brno and Bratislava region, embracing the full quadruple helix of innovation driving actors: excellent scientific teams from Masaryk University and Slovak Academy of Sciences, collaborating with top biotech companies: Geneton, BioVendor, and MultiplexDX. Societal actors will be represented by organisations such as Slovak and Czech Alzheimer Societies, Memory Center and Czech Brain Aging Study. The regional government will be involved via Ministry of Health Slovak Republic, and South Moravian Innovation Centre. The joined ecosystems will unite R&I activities focusing on new diagnostic methods and their applications and further interlink academia and business spheres by creating a pilot industrial PhD programme. ADDIT-CE will generate a joint cross-border strategy covering basic and applied research activities aiming on accelerating the development of new tools for preclinical AD diagnostics and lifestyle/pharmacological intervention monitoring. New cutting-edge technologies will be transferred into clinical practise. Results of ADDIT-CE will be used to develop the Slovak National Plan to Combat Dementia, to enrich the Czech National Plan for AD, and will be widely disseminated to end users and society. ADDIT-CE will join forces of the involved ecosystems to revolutionise diagnostic approaches in both countries.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores